4CPS-059 Linezolid dosing in patients with liver cirrhosis: standard dosing risks’ toxicity

BACKGROUND: Linezolid is used at a standard dose of 600 mg/12 hours regardless of renal or hepatic function but very little data concerning its pharmacokinetics (PK), efficacy and safety in patients with liver cirrhosis is available. PURPOSE: The objectives were to describe the PK, efficacy and safe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Hosp Pharm
Main Authors: Luque, S, Echeverria-Esnal, D, Martinez-Casanova, J, Gonzalez-Colominas, E, Fernandez-Sala, X, Barcelo, J, Muñoz, R, Alvarez-Lerma, F, Grau, S
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2018
Assuntos:
Section 4: Clinical pharmacy services
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535325/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.150
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados